Angelica, Balaod S.

HRN: 10-98-64  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2026
CLINDAMYCIN 300MG (CAP)
03/26/2026
04/01/2026
PO
300mg
TID
SP NSVD; Hematoma
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: